As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
Featured article: Usefulness of glycated albumin as a predictor of mortality in chronic hemodialysis patients with diabetes: a multi-center, prospective cohort study
The association of glycated albumin (GA) with mortality is unclear in chronic hemodialysis patients with diabetes. We investigated the usefulness of GA by comparing it with hemoglobin A1c (HbA1c) in this patient population.
Featured article: Comparison of clinical effects between icodextrin and glucose solutions on outcomes of peritoneal dialysis: systematic review and meta-analysis of randomized controlled trials
Icodextrin enhances peritoneal filtration for patients on peritoneal dialysis (PD). However, clinically important outcomes have not yet been analyzed using authentic, objective statistical methods. The present systematic review aimed to determine the risks and benefits of icodextrin compared with a glucose-based solution with respect to clinically important and patient-centered outcomes.
Featured article: Proposal of peritoneal biopsy procedures for patients undergoing peritoneal dialysis
Prolonged peritoneal dialysis (PD) is responsible for progressive morphological changes such as deterioration of the peritoneal membrane. These changes increase the risk of encapsulating peritoneal sclerosis (EPS). Histological assessments of peritoneal membrane biopsy samples are fundamental for the evaluation of the peritoneal damage caused by PD.
The 65th Annual Meeting of the Japanese Society for Dialysis Therapy
2-3 November 2020, Osaka International Convention Center, RIHGA Royal Hotel Osaka with WEB meeting
The 66th Annual Meeting of the Japanese Society for Dialysis Therapy
4-6 June 2021, Pacifico Yokohama
The 67th Annual Meeting of the Japanese Society for Dialysis Therapy
30 June - 2 July 202, Pacifico Yokohama
The 31st Annual Meeting of the Japan Society for Blood Purification Critical Care
17-18 October 2020, Kofu Memorial Day's Hotel
The 32nd Annual Meeting of the Japan Society for Blood Purification Critical Care
2-3 October 2021, Rafre Saitama
The 33rd Annual Meeting of the Japan Society for Blood Purification Critical Care
7-8 October 2022, Juroku Plaza
The 11th Annual Meeting of the Japanese Society of Renal Rehabilitation
20-21 March 2021, Sendai International Center
The 14th Annual Meeting of the Japanese Society of Nephrology and Pharmacotherapy
28-29 November 2020, Awagin Hall Tokushima
Submit your manuscript
Please use the online submission system to submit your manuscript. For all enquiries about the journal, please access the site and click Contact Us.
Aims and scope
Renal Replacement Therapy is a peer-reviewed journal facilitating worldwide discussion of research and issues related to the study of renal replacement therapy.
RRT considers articles on all aspects of hemodialysis, peritoneal dialysis, blood purification, renal transplantation and regenerative medicine. In addition, the journal publishes content in wider fields such as chronic kidney disease (CKD), acute kidney injury (AKI), critical care medicine and intensive care, bone and mineral metabolism, anemia and iron metabolism, infection, cardiac disease, cerebral disease, diabetes mellitus, hypertension, nutrition, and related social issues. Contributions are encouraged from a global perspective across many disciplines.
Overcoming Language Barriers
If your manuscript could benefit from improvements to the English language, you should have your manuscript reviewed by someone who is fluent in English. For a collection of free resources to help with writing in English please visit here. If you would like professional help, we recommend our affiliates Nature Research Editing Service and American Journal Experts for help with English usage. BMC authors receive 10% off their first submission to either service. Please note that use of an editing service is neither a requirement nor a guarantee of publication.
Renal Replacement Therapy is the official publication of the following societies:
- Japanese Society for Dialysis Therapy (JSDT)
- Japanese Society for Clinical Renal Transplantation (JSCRT)
- Japanese Society for Peritoneal Dialysis (JSPD)
- Japan Society for Blood Purification in Critical Care (JSBPCC)
- Japanese Society of Renal Rehabilitation (JSRR)
- Japanese Society of Nephrology and Pharmacotherapy (JSNP)
- Japanese Society for Pediatric Renal Failure (JSPRF)
About the Editor
Prof Takashi Shigematsu, Editor-in-Chief
Prof Shigematsu is currently Professor and Director of the Division of Nephrology, Department of Internal Medicine at the Wakayama Medical University School of Medicine, Japan. He is also Director of Blood purification Medicine, and Clinical Engineering at Wakayama Medical University Hospital, as well as a member of the International Society of Nephrology and the American Society of Nephrology.
His research interests focus on bone and mineral metabolism within chronic kidney disease (CKD). In addition, he has been investigating and working in fields of hemodialysis, peritoneal dialysis, blood purification medicine in acute kidney injury, kidney transplantation.
Annual Journal Metrics
37.6 days to first decision for reviewed manuscripts only
28.5 days to first decision for all manuscripts
118.9 days from submission to acceptance
25 days from acceptance to publication
33 Altmetric mentions